Log in to save to my catalogue

Use of Chimeric Antigen Receptor T Cells as a Potential Therapeutic for Glioblastoma

Use of Chimeric Antigen Receptor T Cells as a Potential Therapeutic for Glioblastoma

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1907004266

Use of Chimeric Antigen Receptor T Cells as a Potential Therapeutic for Glioblastoma

About this item

Full title

Use of Chimeric Antigen Receptor T Cells as a Potential Therapeutic for Glioblastoma

Publisher

United States: Oxford University Press

Journal title

Neurosurgery, 2017-05, Vol.80 (5), p.N33-N34

Language

English

Formats

Publication information

Publisher

United States: Oxford University Press

More information

Alternative Titles

Full title

Use of Chimeric Antigen Receptor T Cells as a Potential Therapeutic for Glioblastoma

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_1907004266

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1907004266

Other Identifiers

ISSN

0148-396X

E-ISSN

1524-4040

DOI

10.1093/neuros/nyx105

How to access this item